Home Topics Drug Discovery Antibiotics Enhance RNAi Capabilities Antibiotics Enhance RNAi Capabilities July 31, 2008 – Interview with Peng Jin, Ph.D., Assistant Professor, Department of Human Genetics, Emory University School of Medicine /wp-content/uploads/2018/09/gc221_7_31_2008.mp3 PodcastsResourcesAntibioticsCellular, Molecular and Developmental BiologyDrug discoveryDrug research and developmentDrugsMolecular biologyPharmacologyRNA biologyRNA interference Also of Interest New High-Throughput, AI-Based, Protein Prediction Method May Advance Drug Discovery Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Tumor-Like Vasculature of TB Granulomas Inspires New Therapeutic Combos Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline Drug-Resistant Bacteria Stymied by AI-Designed Antibiotics M5 Modulator Enables Tailored Monoclonal Antibody Glycosylation Related Media BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge" Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Related Content New High-Throughput, AI-Based, Protein Prediction Method May Advance Drug Discovery Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Tumor-Like Vasculature of TB Granulomas Inspires New Therapeutic Combos Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline